Definiendo el perfil del paciente candidato a 2 línea tras ITK

Cover

Table of Contents

Table of Contents

Previous Page

13 / 34

Next Page

Information

Previous Page

13 / 34

Next Page

Page Background

Treatment options in 2

nd

-3

rd

line

AXITINIB

NIVOLUMAB

CABOZANTINIB

LENVATINIB +

EVEROLIMUS

Plimarck E, et al .KCS 2016

1 … 8 9 10 11 12 13 14 15 16 17 18 19 … 34 FlippingBook